How do you approach treatment for patients with proliferative glomerulonephritis with monoclonal IgG deposits (PGNMID) with end-stage renal disease who are considering kidney transplant?
Most patients with PGNMID have no detectable disease in their marrow or blood and urine protein cannot adequately be monitored.
1 Answer
Mednet MemberInvited Expert
Medical Oncology · Winship Cancer Institute of Emory University
Answered on
Monoclonal gammopathy of renal significance includes a variety of renal pathologies:
- MIDD (LCDD, LHCDD, HCDD).
- Monoclonal immunotactoid glomerulonephritis or type 1 cryoglobulinemic glomerulonephritis.
- Light chain proximal tubulopathy or crystal-storing histiocytosis.
- C3 glomerulopathy with monoclon...
Join for free or sign in to see the full answer